{
  "id": 2070219,
  "title": "An AI-assisted platform for quantitative histopathological analysis in interstitial lung disease",
  "url": "https://urgent.news/2026/08/19/an-ai-assisted-platform-for-quantitative-histopathological-analysis",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.08.16.745078v1?rss=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "Interstitial lung diseases (ILDs) are heterogeneous pulmonary disorders characterized by chronic inflammation and/or fibrosis. 30--40% of ILD patients develop fibrotic disease that is associated with progressive respiratory decline and poor prognosis, particularly in idiopathic pulmonary fibrosis. Current antifibrotic therapies slow disease progression but do not reverse fibrosis, highlighting…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}